Alzheimer's disease
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Patients - Diagnosis of MCI based on the latest research criteria (clinical assessment at the memory clinic (prof. Frans RJ Verhey): presence of at least a memory impairment, memory complaints expressed by the patient or informant, no problems in daily life functioning, no dementia and presence of biomarkers (Albert et al., 2011) - Clinical Dementia Rating score of 0.5 (CDR distinguishes a stage of questionable dementia (CDR 0.5) from people termed healthy (CDR 0) and those with mild dementia (CDR 1) - Mini-Mental State Examination (MMSE) 23 and being mentally competent (in general, individuals with a MMSE 18 are considered mentally competent) - Age: between 60 and 85 years old - 50% female - Right-handedness - Average level of education (CBS level 3-4-5-6);Healthy controls - Average neuropsychological test results, in accordance with normative data, corrected for age, education and gender - No substantial memory complaints (according to the participant) - Age: between 60 and 85 years old - 50% female - Right-handedness - Average level of education (CBS level 3-4-5-6) - Normal or corrected to normal vision
Exclusion criteria
Exclusion criteria: - Psychoactive medication use - Abuse of alcohol and drugs - Cognitive impairment due to alcohol/drug abuse or abuse of other substances - Past or present psychiatric or neurological disorders (major depression, schizophrenia, bipolar disorder, psychotic disorder (or treatment for it), epilepsy, stroke, Parkinson*s disease, multiple sclerosis, brain surgery, brain trauma, electroshock therapy, kidney dialysis, Menière*s disease, brain infections) - Major vascular disorders (e.g. stroke) - Heart diseases or pacemakers - Contraindications for scanning (e.g. brain surgery, cardiac pacemaker, metal implants, claustrophobia, body tattoos) - Large scars or fresh wounds on the scalp
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The main outcome measures are the Blood Oxygenation Level Dependent (BOLD) reflecting brain activity during the functional task and functional connectivity changes reflecting network integrity. | — |
Secondary
| Measure | Time frame |
|---|---|
| Secondary study parameters are performance on a pattern separation episodic memory task (accuracy and reaction times). Performance on the task will be correlated with BOLD-signal per session. | — |
Countries
Netherlands